Abstract：Although drug-coating technologies have made stent achieve a great progress, and the application of drug-coating stents is more than that of non-drug coating stents in clinical application. However, the long-term efficacy still required further observation and verification. Regardless of what types of drug-coating stents, when the stent was implanted in the body for a long time, the drug coating would be gradually absorbed and the bare stent was exposed to the blood and the vein wall, therefore, the problems of the non-drug coating stents can not be completely solved. Bioresorbable stents are different from the non-degradable stents, they can be degraded when implanted in the human body. After a period of time, it is degraded completely and excreted. This paper not only described various bioresorbable stents, including polymer, magnesium alloy, pure iron, zn-alloy, but also analyzed existing problems, aiming to make a contribution to the development and application of bioresorbable stents.
[1] Zhang Jing. Stent thrombosis in patients with coronary artery disease treated with biodegradable polymer drug-eluting stents: an update meta-analysis[J]. Int Heart J, 2014, 55(3):213-218. [2] Onuma Y, Serruys PW. Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?[J] Circulation, 2011, 123(7):779-797. [3] Giustino G, Baber U, Sartori S, et al. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials [J]. J Am Coll Cardiol, 2015, 65(13):1298-1310. [4] Ribeiro EE, Campos CM, Ribeiro HB, et al.First-in-man randomised comparison of a novel sirolimus-eluting stent with abluminal biodegradable polymer and thin-strut cobalt-chromium alloy: INSPIRON-I trial [J]. Euro Intervention, 2014, 9(12):1380-1384. [5] Waksman R, Pakala R, Kuchulakanti PK, et al. Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries [J]. Catheter Cardiovasc Interv, 2006, 68(4):607-617. [6] Stefanini GG, Taniwaki M, Windecker S. Coronary stents: Novel developments [J]. Heart, 2014, 100(13):1051-1061. [7] Alexy RD, Levi DS. Materials and manufacturing technologies available for production of a pediatric bioabsorbable stent [J]. Biomed Res Int, 2013, 2013:137985. [8] Vroman I, Tighzert L. Biodegradable polymers [J]. Materials, 2009, 2(2):307-344. [9] Stack RS, Califf RM, Phillips HR, et al.Interventional cardiac catheterization at Duke Medical Center[J].Am J Cardiol, 1988, 62(10 Pt 2):3F-24F. [10] van der Giessen WJ, Lincoff AM, Schwartz RS, et al.Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries [J]. Circulation, 1996, 94(7):1690-1697. [11] Regar E, Sianos G, Serruys PW. Stent development and local drug delivery [J]. Br Med Bull, 2001, 59:227-248. [12] Asplund B, Sperens J, Mathisen T, et al.Effects of hydrolysis on a new biodegradable co-polymer [J]. J Biomater Sci Polym Ed, 2006, 17(6):615-630. [13] Lincoff AM, Furst JG, Ellis SG, et al. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model[J]. J Am Coll Cardiol, 1997, 29(4):808-816. [14] Ruef J, Hofmann M, Haase J. Endovascular interventions in iliac and infrainguinal occlusive artery disease[J]. J Interv Cardiol, 2004, 17(6):427-435. [15] Foin N, Gutiérrez-Chico JL, Nakatani S, et al. Incomplete stent apposition causes high shear flow disturbances and delay in neointimal coverage as a function of strut to wall detachment distance: implications for the management of incomplete stent apposition[J]. Circ Cardiovasc Interv, 2014, 7(2):180-189. [16] Bosiers M, Peeters P, D’Archambeau O, et al. AMS INSIGHT—absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis[J]. Cardiovasc Intervent Radiol, 2009, 32(3):424-435. [17] Zartner P, Cesnjevar R, Singer H, et al.First successful implantation of a biodegradable metal stent into the left pulmonary artery of a preterm baby[J]. Catheter Cardiovasc Interv, 2005, 66(4):590-594. [18] Schranz D, Zartner P, Michel-Behnke I, et al.Bioabsorbable metal stents for percutaneous treatment of critical recoarctation of the aorta in a newborn[J]. Catheter Cardiovasc Interv, 2006, 67(5):671-673. [19] Waksman R, Pakala R, Kuchulakanti PK, et al.Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries[J]. Catheter Cardiovasc Interv, 2006, 68(4):607-617. [20] BaoLin G, Ma PX. Synthetic biodegradable functional polymers for tissue engineering: A brief review [J]. Sci China Chem, 2014, 57(4):490-500. [21] Heublein B, Rohde R, Kaese V, et al. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? [J] Heart, 2003, 89(6):651-656. [22] Moravei M, Mantovani D. Biodegradable metals for cardiovascular stent application: interests and new opportunities [J]. Int J Mol Sci, 2011, 12(7):4250-4270. [23] Peuster M, Wohlsein P, Brügmann M, et al. A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal-results 6-18 months after implantation into New Zealand white rabbits [J]. Heart, 2001, 86(5):563-569. [24] Peuster M, Hesse C, Schloo T, et al. Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta [J]. Biomaterials, 2006, 27(28):4955-4962. [25] Pierson D, Edick J, Tauscher A, et al. A simplified in vivo approach for evaluating the bioabsorbable behavior of candidate stent materials [J]. J Biomed Mater Res B Appl Biomater, 2012, 100(1):58-67. [26] Bowen PK, Drelich J, Goldman J. Zinc exhibits ideal physiological corrosion behavior for bioabsorbable stents [J]. Adv Mater, 2013, 25(18):2577-2582. [27] Bowen PK, Guillory RJ 2nd, Shearier ER, et al. Metallic zinc exhibits optimal biocompatibility for bioabsorbable endovascular stents[J]. Mater Sci Eng C Mater Biol Appl, 2015, 56:467-472. [28] Mostaed E, Sikora-Jasinska M, Mostaed A, et al. Novel Zn-based alloys for biodegradable stent applications: Design, development and in vitro degradation[J]. J Mech Behav Biomed Mater, 2016, 60:581-602. [29] Natsuaki M, Kozuma K, Morimoto T, et al. Two-year outcome of a randomized trial comparing second-generation drug-eluting stents using biodegradable or durable polymer[J].JAMA, 2014, 311(20):2125-2127. [30] Foin N, Lee RD, Torii R, et al. Impact of stent strut design in metallic stents and biodegradable scaffolds [J]. Int J Cardiol, 2014, 177(3):800-808. [31] Boland EL, Shine R, Kelly N, et al. A Review of Material Degradation Modelling for the Analysis and Design of Bioabsorbable Stents [J]. Ann Biomed Eng, 2016, 44(2):341-356.
